- All audiences: Faculty, researchers, students, and the general public who might be interested in hearing fascinating stories of research
|A podcast series highlighting fascinating stories of medical research||ThinkResearch Podcast|
We all are impacted by, and reap the benefits of, medical research discoveries. From over-the-counter drugs, to healthcare policies and educational interventions, many of these advancements are a result of incredible feats, decades of work, and sometimes serendipitous events. Join us as we sit down with Harvard researchers to discuss these captivating behind-the-scenes stories of research.
Ankur Pandya, PhD, is an assistant professor of health decision science in the Department of Health Policy and Management at the Harvard T.H. Chan School of Public Health. His areas of interest are: applied decision science studies evaluating cardiovascular disease policies; connecting cost-effectiveness analysis with broader value-based health policies being implemented or piloted in U.S. health reform; and methodological topics within disease simulation modeling. Pandya's research has been covered in The New York Times, National Public Radio, NBC Nightly News, and other media outlets. He holds a BS from Cornell University in Nutritional Sciences, an MPH from Yale University in Health Policy and Administration, and graduated from the Harvard PhD Program in Health Policy.
Corrie Painter, PhD, is the associate director of operations and scientific outreach at the Broad Institute. A trained cancer researcher with a PhD in biochemistry, Painter partners with advocacy groups and engages patients with metastatic breast cancer through social media in order to carry out the Metastatic Breast Cancer Project, a genomics study conducted at the Broad Institute where patients can consent online to donate their stored tumor samples, saliva, medical records, and their voice in order to directly accelerate the pace of discovery.
Anupam B. Jena, MD, PhD, is the Ruth L. Newhouse Associate Professor of Health Care Policy at Harvard Medical School and a physician in the Department of Medicine at Massachusetts General Hospital. He is also a faculty research fellow at the National Bureau of Economic Research. As an economist and a physician, Jena's research involves several areas of health economics and policy including the economics of physician behavior and the physician workforce, healthcare productivity, medical malpractice, and the economics of medical innovation. His work has been published in leading journals of medicine and economics and been featured in the New York Times, Washington Post, and other prominent news outlets. His work has been featured in several Freakonomics podcasts. Jena graduated Phi Beta Kappa from the Massachusetts Institute of Technology with majors in biology and economics. He received his MD and PhD in Economics from the University of Chicago, where he was funded by the NIH Medical Scientist Training Program. Jena completed his residency in internal medicine at Massachusetts General Hospital. In 2007, he was awarded the Eugene Garfield Award by Research America for his work demonstrating the economic value of medical innovation in HIV/AIDS. In 2013, Jena received the NIH Director's Early Independence Award to fund research on the physician determinants of healthcare spending, quality, and patient outcomes. In 2015, he was awarded the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) New Investigator Award. From 2014-15, Jena served as a member of the Institute of Medicine Committee on Diagnostic Errors in Healthcare.
I-Min Lee, MD, ScD, FACSM, is a professor of medicine at Harvard Medical School and professor of epidemiology at the Harvard T.H. Chan School of Public Health. Her primary area of interest is in the role of physical activity for preventing chronic diseases and enhancing longevity. Lee has served on national and international expert panels developing physical activity guidelines, including the 2008 US Physical Activity Guidelines, the 2010 WHO Global Recommendations on Physical Activity for Health, and the 2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk.
Rebekka Lee, ScD, is a research scientist at the Harvard T.H. Chan School of Public Health. She has spent the past decade working at the Prevention Research Center on Nutrition and Physical Activity, where she currently uses mixed methods to conduct evaluation research with partners at the Boston Public Health Commission, Massachusetts Department of Public Health, and YMCA. Her research focuses on designing and evaluating community-based interventions that translate into real world policy and environmental change, focusing in particular on investigating the contextual factors that impact effective implementation and promote health equity. Lee completed her masters and doctoral degrees in the Department of Social and Behavior Sciences at the Harvard School of Public Health. She also serves as an Evaluation Consultant and instructor for the Population Health Research Program at Harvard Catalyst | The Harvard Clinical and Translational Science Center, providing training and technical assistance on mixed methods, implementation science, and community-based participatory research. Part of her work at Harvard Catalyst is leading a mixed methods implementation evaluation of nine clinical and community partnerships participating in the Prevention and Wellness Trust Fund. She was selected for the inaugural cohort of the Mentored Training for Dissemination and Implementation Research in Cancer and honed her knowledge of mixed methods in a master course with John W. Creswell, PhD.
Julie Buring, ScD, is a professor of medicine at Harvard Medical School and Brigham and Women's Hospital, and a professor of epidemiology at the Harvard T. H. Chan School of Public Health. The primary focus of her research is on the prevention of chronic diseases, especially among women. Buring has been involved in the design, conduct, analysis, and interpretation of a number of large-scale randomized clinical trials of the primary prevention of cardiovascular disease, cancer, and other chronic diseases. These include the Women's Health Study, evaluating the preventive roles of aspirin and vitamin E; the Physicians' Health Study II, evaluating vitamin E, vitamin C, beta-carotene, and a multivitamin; and VITAL, an ongoing trial of vitamin D and fish oil. She is actively involved in the teaching and training of students and fellows in epidemiology, both nationally and internationally, and is co-director of an NIH T32 training grant in the Epidemiology of Cardiovascular Disease. Buring serves as chair of the Institutional Review Board of Harvard Medical School.
JoAnn Manson, MD, MPH, DrPH is professor of medicine and the Michael and Lee Bell Professor of Women's Health at Harvard Medical School. She is also chief of the Division of Preventive Medicine and co-director of the Connors Center for Women's Health and Gender Biology at Brigham and Women's Hospital. Manson is an endocrinologist, epidemiologist, and principal investigator of several research studies, including the VITamin D and OmegA-3 TriaL (VITAL); the Women's Health Initiative Clinical Center in Boston; the cardiovascular component of the Nurses' Health Study; the COcoa Supplement and Multivitamin Outcomes Study (COSMOS); and the Boston site of the Kronos Early Estrogen Prevention Study. She has received numerous honors, including the Woman in Science Award from the American Medical Women's Association, the American Heart Association's (AHA) Population Research Prize, the AHA's Distinguished Scientist Award, election to the Institute of Medicine of the National Academies (National Academy of Medicine), membership in the Association of American Physicians (AAP), and the 2013 Bernadine Healy Award for Visionary Leadership in Women's Health.
Peter Steinberg, MD, is Assistant Professor of Surgery at Harvard Medical School and Director of Endourology and Stone Management at BIDMC. He earned his medical degree from the University of Pennsylvania School of Medicine in Philadelphia. Dr. Steinberg completed a residency in urology at Dartmouth-Hitchcock Medical Center in New Hampshire and a fellowship in robotics, laparoscopy, and endourology at Montefiore Medical Center in New York. Board certified in urology, Dr. Steinberg's clinical interests include laparoscopy, robotics, and endourology, kidney stones, and general urology.
Jeff Karp, PhD, is a world leader in drug delivery, stem cell therapeutics, and tissue adhesives. He is an Associate Professor at Brigham and Women's Hospital, Harvard Medical School, Principal Faculty at the Harvard Stem Cell Institute, and an affiliate faculty at the Broad Institute and at the Harvard-MIT Division of Health Sciences and Technology.
Bio: Laura Riley, MD, a Boston native, received her undergraduate education at Harvard University; her medical degree at the University of Pittsburgh and her residency in obstetrics and gynecology at the University of Pittsburgh-Magee Women's Hospital. She completed subspecialty training in maternal-fetal medicine at Brigham and Women's Hospital and in infectious disease at Boston University Medical Center. She is an Associate Professor of Obstetrics, Gynecology and Reproductive biology at Harvard Medical School. Dr. Riley joined the obstetrical service at Massachusetts General Hospital in 1995, where she focuses on high-risk pregnancy with an emphasis on infectious disease complications of obstetrics and she is the Vice Chair for Obstetrics. Nationally, serves as a consultant to the Centers for Disease Control on H1N1, Ebola virus, and Zika virus guidelines; she is the first ob/gyn member of the Advisory Committee on Immunization Practice.
Bio: Charles Deutsch, ScD is Director of the Harvard Catalyst Population Health Research Program (PHRP). Dr. Deutsch is responsible for the day-to-day leadership and operations of PHRP, which is the focal point for Harvard Catalyst's community engagement and population health research translation activities. Throughout his career he has worked to demonstrate coordinated and results-oriented engagement of academic health centers in applying what we know to what we do in health programs and policies.
Bio: Enrico Cagliero, MD, completed his internship and residency at the University of California, San Diego, and his fellowship in Endocrinology at Massachusetts General Hospital. He then became an independent investigator at Harvard Medical School in 1990 and worked on the cellular mechanisms responsible for the vascular complications of diabetes. Cagliero joined the Diabetes Center at Massachusetts General Hospital in 1995, where he is now dividing his time between a busy clinical practice and his clinical research efforts. His major research interests include islet cell transplant for the treatment of type 1 diabetic patients and the development of new interventions for the prevention and treatment of type 1 and type 2 diabetes.
Bio: Elliott Antman, MD, is professor of medicine and an associate dean for Clinical/Translational Research at Harvard Medical School, a senior investigator in the Thrombolysis in Myocardial Infarction (TIMI) Study Group, and a senior physician in the Cardiovascular Division of Brigham and Women's Hospital in Boston, Massachusetts. He was president of the American Heart Association (2014-2015) and is now the immediate past president. The American Heart Association honored him with the 2016 Paul Dudley White Award.
Have ideas about what you would like to hear on the podcast? Email us!